Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: A randomized, double-blind, bilateral comparison study [16]

British Journal of Dermatology

Volumn 156, Issue 1, 2007, Pages 191-192

  Tzung, T Y ^a,b   Liu, Y S ^a   Chang, H W ^c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOLOGICAL PROCEDURES; DESQUAMATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FEMALE; HUMAN; LETTER; MALE; MICRODERMABRASION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SKIN INDURATION; SKIN LUPUS ERYTHEMATOSUS; TELANGIECTASIA;

ADULT; CLOBETASOL; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MALE; OINTMENTS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33845539315     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07595.x     Document Type: Letter

References (10)

1. Goodfields MD, Johns SK, Veale DJ. The 'connective tissue disease'. In: Rook's Textbook of Dermatology (Burns T, Breathnach SM, Cox NH, Griffiths CEM, eds), 7th edn, Vol. 3. Oxford: Blackwell Publishing, 2004; 56.21-56.22.
2. Nghiem P, Pearson G, Langley RG. Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis. J Am Acad Dermatol 2002; 46:228-41.
3. Yoshimasu T, Ohtani T, Sakamoto T et al. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol 2002; 12:50-2.
4. Kanekura T, Yoshii N, Terasaki K et al. Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus. Br J Dermatol 2003; 148:353-6.
5. Lampropoulos CE, Sangle S, Harrison P et al. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford) 2004; 43:1383-5.
6. Heffernan MP, Nelson MM, Smith DI et al. 0.1% Tacrolimus ointment in the treatment of discoid lupus erythematosus. Arch Dermatol 2005; 141:1170-1.
7. Walker SL, Kirby B, Chalmers RJ. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 2002; 147:405-6.
8. Remitz A, Reitamo S, Erkko P et al. Tacrolimus ointment improves psoriasis in a microplaque assay. Br J Dermatol 1999; 141:103-7.
9. Rajan P, Grimes PE. Skin barrier changes induced by aluminum oxide and sodium chloride microdermabrasion. Dermatol Surg 2002; 28:390-3.
10. Fang JY, Lee WR, Shen SC et al. Enhancement of topical 5-amino-laevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 2004; 151:132-40.